Navy General Hospital, Beijing
Navy General Hospital, Beijing
Explore linked clinical trials.28 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism | Embolism, Embolism and Thrombosis, Pulmonary Thromboembolisms, Thromboembolism, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolism | Recruiting | Not applicable | 2026-09-09 | NCT06382038 | |
| Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Not yet recruiting | Not applicable | 2026-04-06 | NCT07512037 | |
| Burden-Evaluated Atrial Fibrillation Progession and ThromboEmbolim Study BEAT-AF TE Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Not yet recruiting | Not stated | 2026-03-27 | NCT07497906 | |
| Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotions in Patients Undergoing Cardiac Surgery | Confusion, Emergence Delirium, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, anxiety, anxiety disorder, cognitive disorder, delirium, depressive disorder, nervous system disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-03-17 | NCT07476742 | |
| 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Phase 1 | 2026-02-27 | NCT07438847 | |
| A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic kidney disease, chronic renal failure syndrome, hypertensive disorder, kidney disorder, kidney failure, urinary system disorder, vascular disorder | Enrolling by invitation | Not applicable | 2026-02-11 | NCT07130955 | |
| Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease | Deglutition Disorders, Digestive System Diseases, Ventricular Outflow Obstruction, aortic valve disorder, aortic valve insufficiency, aortic valve stenosis, cardiovascular disorder, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease, heart disorder, heart valve disorder, mitral valve disorder, mitral valve stenosis, pulmonary valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Recruiting | Not stated | 2025-12-05 | NCT07267117 | |
| G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma | Aggressive B-Cell Lymphoma | Not yet recruiting | Phase 2 | 2025-09-22 | NCT07184788 | |
| Pola-ZR2P in Previously Untreated DLBCL | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-08-19 | NCT06664411 | |
| G-Pola-ZLP in Diffuse Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2025-08-14 | NCT06665217 | |
| Impact of Remimazolam on Prognosis After Bladder Cancer Surgery | Confusion, Emergence Delirium, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, cognitive disorder, delirium, neoplasm, nervous system disorder, psychiatric disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 4 | 2025-07-30 | NCT04532606 | |
| The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Not yet recruiting | Phase 2 | 2025-07-15 | NCT07064889 | |
| Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Not yet recruiting | Phase 2 | 2025-07-10 | NCT07057778 | |
| Smart Technology Facilitated Patient-centered Venous Thromboembolism Management | Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, vascular disorder, venous thromboembolism | Enrolling by invitation | Not applicable | 2025-05-31 | NCT06350331 | |
| Study on Cardiac Output Evaluation Based on Wearable Monitoring Data | Cardiac Output | Not yet recruiting | Not stated | 2025-04-22 | NCT06938893 | |
| SIL as Maintenance Therapy in Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 2 | 2024-12-20 | NCT06744894 | |
| Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-10-29 | NCT06176027 | |
| VA as Maintenance Therapy Post Allo-HSCT in MDS and AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 2 | 2024-10-01 | NCT06598384 | |
| VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS | Higher-risk Myelodysplastic Syndromes | Recruiting | Phase 1 / Phase 2 | 2024-10-01 | NCT06471946 | |
| Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2024-09-19 | NCT06503263 | |
| CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 2 | 2024-08-22 | NCT06470841 | |
| Effect of Aerobic Interval Training on Atrial Fibrillation Burden | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Not yet recruiting | Not applicable | 2024-08-02 | NCT06491329 | |
| Smart Technology Facilitated Patient-centered Venous Thromboembolism Management | Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, vascular disorder, venous thromboembolism | Not yet recruiting | Not applicable | 2024-07-17 | NCT06350344 | |
| Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma; Relapsed Classic Hodgkin Lymphoma | Recruiting | Phase 2 | 2024-01-30 | NCT06190067 | |
| Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL | primary central nervous system lymphoma | Recruiting | Phase 2 / Phase 3 | 2020-09-09 | NCT02836158 |